期刊文献+

利用UPLC/Q-TOF MSMS对孤独症患儿血清的代谢组学分析 被引量:6

Metabonomics analysis of serum in autistic children using ultra performance liquid chromatography and Q-TOF mass spectrometry
原文传递
导出
摘要 【目的】对孤独症和正常儿童进行血清代谢组学分析,找出特异性代谢产物,为孤独症的早期筛查诊断提供实验依据。【方法】采用超高效液相色谱与四级杆飞行时间串联质谱仪联用技术(UPLC/Q-TOF MSMS)和模式识别方法,对孤独症儿童(n=73)和正常对照儿童(n=63)的血清进行代谢组学分析,找出与孤独症相关的特异性代谢产物。【结果】主成分分析得分图显示孤独症组和对照组形成明显的分类,说明孤独症血清代谢谱发生了明显改变,在正离子模式和负离子模式下共鉴定出14个潜在生物标志物。孤独症组的鞘脂类和溶血磷脂类物质明显增多,而多元不饱和脂肪酸(PUFAs)和脂酰肉毒碱明显减少。【结论】孤独症患儿和正常对照组在血清代谢水平上存在明显差异。此发现为找出孤独症诊断的潜在标志物提供了新的依据,并为孤独症的干预提供新的靶点。 【Objective】 To investigate the metabolite alterations in the serum of autistic children and normal children using metabolomics profiling,discover specific biomarkers of autistic children,and provide experimental evidence for the early screening and diagnosis of children with autism. 【Method】 Ultra performance liquid chromatography and Q-TOF mass spectrometry(UPLC/Q-TOF MSMS) and pattern recognition were used to the Metabolomic Profiling of autistic children(n=73)and normal children(n=63),in order to discover the special metabolites. 【Results】 There were significant differences in serum metabolites of the autism group and control group within a total of 14 biomarkers in the positive and negative mode.Lysophosphatidic and sphingolipids increased in the autism group;Acylcarnitine and PUFAs reduced in the autism group. 【Conclusion】 There are significant differences in serum metabolites of children with autism and normal children that help to provide a basis for discovering potential markers useful for autism diagnosis,and provide new targets for autism intervention.
出处 《中国儿童保健杂志》 CAS 北大核心 2013年第1期6-9,12,共5页 Chinese Journal of Child Health Care
基金 国家自然科学基金(81172682) 国家自然科学基金(81072315) 国家自然科学基金(81072298) 卫生部公益性行业科研专项经费(201202010) 国家重点基础研究发展计划项目(2012CB517900)
关键词 UPLC Q-TOFMSMS 代谢组学 孤独症 UPLC/Q-TOF MSMS metabonomics autism
  • 相关文献

参考文献18

  • 1Main PA, Angley MT, Thomas P, et al. Folate and methio nine metabolism in autism: a systematic review[J]. Am J Clin Nutr,2010,91(6) ~1598 1620.
  • 2Iwata K, Matsuzaki H, Miyachi T, et al. Investigation of the serum levels of anterior pituitary hormones in male children with autism[J]. Mol Autism, 2011,19 (2) : 16-24.
  • 3庞伟,康倩倩,郭岚敏,王景涛,姜志梅.孤独症儿童血浆多不饱和脂肪酸水平研究[J].中国康复理论与实践,2011,17(8):742-744. 被引量:8
  • 4Yap IK, Angley M, Veselkov KA, et al. Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls[J]. J Proteome Res, 2010,9(6) : 2996-3004.
  • 5Nicholson JK, Wilson ID. Understanding 'global" systems bi- ology: metabonomies and the continuum of metabolism[J]. Nat Rev Drug Discov, 2003,2 : 668-676.
  • 6Issaq HJ, Abbott E, Veenstra TD. Utility of separation sci- ence in metabolomic studies [J]. J Sep Sci, 2008, 31 (11) : 1936-1947.
  • 7EI-Ansary AK,Bacha AG, A1-Ayahdi LY. Plasma fatty acids as diagnostic markers in autistic patients from saudi arabia [J]. Lipids Health Dis, 2011,21 (10): 62-71.
  • 8Wiest MM, German JB, Harvey DJ, et al. Plasma fatty acid profiles in autism: A case-control study[J]. Prostaglandins Leukotr Essent Fatty Acids, 2009,80 : 221-227.
  • 9Tamiji J,Crawford DA. The neurobiology of lipid metabo lism in autism spectrum disorders[J]. Neurosignals, 2010, 18(2) :98-112.
  • 10Yui K, Koshiba M, Nakamura S,et al. Effects of large doses of araehidonic acid added to docosahexaenoic acid on social impairment in individuals with autism spectrum disorders:a double-blind, placebo-controlled, randomized trial [ J ]. J Clin Psychopharmacol, 2012,32 (2) : 200-206.

二级参考文献14

  • 1Sethom MM, Fares S, Bouaziz N, et al. Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia [J]. Prostaglandins Leukot rienes Essent Fatty Acids, 2010.83 (3): 131 - 136.
  • 2Assies J, Mocking R J, Pouwer F. Maternal depression and child development after prenatal DHA supplementation [J]. JAMA, 2011. 305(4): 360; author reply 360-361.
  • 3Jans LA, Giltay E J, van der Does AJ. The efficacy of n-3 fatty acids DHA and EPA (fish oil) for perinatal depression [J]. Br J Nutr, 2010. 104(11): 1577-1585.
  • 4Freeman MP, Rapaport MH. Omega-3 fatty acids and depres- sion: from cellular mechanisms to clinical care [J]. J Clin Psychiatry, 2011, 72(2): 258-259.
  • 5Bousquet M, Gue K, Emond V, et al. Transgenic conversion of omega-6 into omega-3 fatty acids in a mouse model of Parkin- son's disease [J]. J Lipid Res, 2011, 52(2): 263-271.
  • 6Meiri G, Bichovsky Y, Belmaker RH. Omega 3 fatty acid treatment in autism [J]. J Child Adolesc Psychopharmacol, 2009, 19 (4): 449-451.
  • 7Decsi T, Koletzko B. Fatty acid composition oi plasma lipid classes in healthy subjects from birth to young adulthood [J]. Eur J Pediatr, 1994, 1153(7): 520-525.
  • 8Sliwinski S, Croonenberghs J, Christophc A, et al. Polyunsatu- rated fatty acids: do they have a role in the pathophysiology of autism [J]. Neuro Endocrinol Lett, 2006, 27(4): 465-471.
  • 9Bell J, LIVlacKinlay E, Dick J, et" al. Essential fatty acids and phospholipase A2 in autistic spectrum disorders [J]. Prostaglan- dins Leukot rienes Essent Fatty Acids, 2004, 71(4): 201-204.
  • 10Bu B, Ashwood P, Harvey D, et al. Fatty acid Compositions ot red blood cell phospholipids in children with autism [J]. Prosta- glandins Leukot rienes Essen Fatty Acids, 2006, 74(4): 215-221.

共引文献7

同被引文献44

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部